Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02266576 · ClinicalTrials.gov registry record · NA

A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians

A NA study, sponsored by Stanford University.

Completed
Registry status
NA
Development phase
207
Enrollment target

NCT02266576: Completed NA study, sponsored by Stanford University.

NCT02266576 is a NA study that has completed, run by Stanford University. The registered enrollment target is 207 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT02266576, a NA study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

The goal of the proposed research is to identify effective patient-centered strategies to prevent diabetes in high-risk populations in real world settings. The investigators will accomplish this by conducting a randomized controlled trial comparing an enhanced Diabetes Prevention Program addressing psychosocial stressors to a standard version in a high-risk population of urban American Indian and Alaska Native people within a primary care setting.

Primary Outcome

BMI is measured as weight in kg divided by the square of height in meters.

Interventions

  • BEHAVIORAL Standard DPP
  • BEHAVIORAL Enhanced DPP

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2015-06
Est. Completion 2017-08-30
Phase NA
Stanford University

1,744 total trials

What the finished NCT02266576 record still lists

NCT02266576 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which Standard DPP is the first listed.

NCT02266576 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02266576 about?

NCT02266576 is a clinical study titled "A Patient-Centered Strategy for Improving Diabetes Prevention in Urban American Indians". The goal of the proposed research is to identify effective patient-centered strategies to prevent diabetes in high-risk populations in real world settings. The investigators will accomplish this by conducting a randomized controlled trial comparing an enhanced Diabetes Prevention Program addressing ...

What is the current status of trial NCT02266576?

This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2015-06. Estimated completion is 2017-08-30.

What interventions are being tested in trial NCT02266576?

The interventions under investigation include: Standard DPP (BEHAVIORAL), Enhanced DPP (BEHAVIORAL).

Who is sponsoring clinical trial NCT02266576?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02266576's enrollment target sits among peer trials

207 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02266576, the US trial registry maintained by the National Library of Medicine. NCT02266576 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.